Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Access Medical Labs will run the Siemens Health FDA Authorized reagent under their EUA at its State of the Art Facility in Jupiter, FL.
read more
Tuesday, November 29, 2016
Accinov of Lyon, France, and Biodextris of Laval, QC, Canada, have announced the signing of a co-marketing agreement, presenting customers with an alternative to traditional contract development and manufacturing organizations (CDMO) for the ...
read more
Tuesday, November 19, 2019
Accord Healthcare Limited and ADIENNE Pharma & Biotech have entered into an exclusive licensing and distribution agreement for the commercialization of TEPADINA.
read more
Accuratus Lab Services and its principal owner, Ampersand Capital Partners, have announced the acquisition of the chemistry, manufacturing and controls (CMC) operation of Array BioPharma.
read more
TetraScience has joined forces with ACD/Labs, a provider of scientific R&D software, to help pharma and biopharma customers achieve greater scientific insights.
read more
ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, will introduce LUMINATA™, an informatics system that enables organizations to establish effective impurity control strategies. ...
read more
Acella Pharmaceuticals announced an exclusive, multi-year, multi-product development and licensing partnership with Catalent Pharma Solutions to develop, manufacture, and commercialize abuse-deterrent pain relief products leveraging Catalent's ...
read more
Acentrus Specialty has signed a strategic agreement with LicenseLogix to provide license compliance services to Acentrus clients.
read more
Thursday, February 20, 2020
Acentrus Specialty™ and Loopback Analytics have reached a collaboration agreement to build a network of health systems with specialty pharmacy operations.
read more
Wednesday, October 31, 2018
Acerus announced the signing of an amendment to its existing licensing and supply agreement with medac, expanding the exclusive right to 28 current EU member countries.
read more
Acerus has reached a mutual agreement with Innovus to terminate the exclusive distributor and license agreement granting Acerus the rights to commercialize UriVarx® in Canada.
read more
Tuesday, December 22, 2020
Aceto announced its acquisition of New York-based, IsleChem.
read more
Aceto has announced its acquisition of Syntor Fine Chemicals.
read more
Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generic pharmaceuticals, nutraceutical products, agricultural protection products ...
read more
Wednesday, January 26, 2022
Aceto has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, ...
read more